Trial Profile
Therapeutic Efficacy Ratio and Symptom Improvement Effect of New Potassium Ion-Competitive Acid Blocker (P-CAB)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 19 May 2016
Price :
$35
*
At a glance
- Drugs Vonoprazan (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 30 Jul 2015 New trial record